Thomas De Beer, RheaVita
A Belgian manufacturer looks to pit its freeze drying process against mRNA — and beyond
When the Covid-19 vaccine was first rolled out by drugmakers, Dippin’ Dots was on the minds of scientists. Not because they were excited to eat the “ice cream of the future” at baseball games and county fairs again, but because the beaded dessert must be stored at -49 degrees Fahrenheit, similar to the doses of Pfizer and Moderna’s mRNA vaccine. In a crunch, Dippin’ Dots was called upon to help transport the first of the vaccine doses before freezers were more widely available.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.
